Brian Park, PharmD

Drug Information Specialist https://www.psychiatryadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Schizophrenia and Psychoses

FDA Approves First Transdermal Patch for Treatment of Schizophrenia

Brian Park, PharmD

October 23, 2019

The FDA has approved Secuado (asenapine; Noven) transdermal system for the treatment of adults with schizophrenia.

General Psychiatry

FDA Panel Votes on OTC Nicotine Mouth Spray for Smoking Cessation

Brian Park, PharmD

September 25, 2019

Nicotine mouth spray is currently approved as a smoking cessation aid in many countries outside the US.

Sleep-Wake Disorders

FDA Approves Wakix For Excessive Daytime Sleepiness In Adults With Narcolepsy

Brian Park, PharmD

August 20, 2019

The Food and Drug Administration (FDA) approved Wakix (pitolisant; Harmony Biosciences) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.

General Psychiatry

FDA Warns of “Cure-All” Products That Actually Contain Bleach

Brian Park, PharmD

August 20, 2019

The FDA is warning consumers to stop using products known as Miracle or Master Mineral Solution, Miracle Mineral Supplement, MMS, Chlorine Dioxide Protocol, and Water Purification Solution due to numerous reports of significant health issues.

Next post in General Psychiatry

Brian Park, PharmD

All articles by Brian Park, PharmD

FDA Approves First Transdermal Patch for Treatment of Schizophrenia

FDA Panel Votes on OTC Nicotine Mouth Spray for Smoking Cessation

FDA Approves Wakix For Excessive Daytime Sleepiness In Adults With Narcolepsy

FDA Warns of “Cure-All” Products That Actually Contain Bleach

Recent Stressful Life Events Linked to Later Verbal Memory Decline